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Background: Gene copy number variation plays a large role in the evolution of genomes. In Rattus norvegicus and
other rodent species, the Y-chromosome has accumulated multiple copies of Sry loci. These copy number variations
have been previously linked with changes in phenotype of animal models such as the spontaneously hypertensive
rat (SHR). This study characterizes the Y-chromosome in the Sry region of Rattus norvegicus, while addressing functional
variations seen in the Sry protein products.
Results: Eleven Sry loci have been identified in the SHR with one (nonHMG Sry) containing a frame shift mutation. The
nonHMGSry is found and conserved in the related WKY and SD rat strains. Three new, previously unidentified, Sry loci
were identified in this study (Sry3BII, Sry4 and Sry4A) in both SHR and WKY. Repetitive element analysis revealed
numerous LINE-L1 elements at regions where conservation is lost among the Sry copies. In addition we have identified
a retrotransposed copy of Med14 originating from spliced mRNA, two autosomal genes (Ccdc110 and HMGB1) and a
normal mammalian Y-chromosome gene (Zfy) in the Sry region of the rat Y-chromosome. Translation of the sequences
of each Sry gene reveals eight proteins with amino acid differences leading to changes in nuclear localization and
promoter activation of a Sry-responsive gene. Sry-β (coded by the Sry2 locus) has an increased cytoplasmic fraction due
to alterations at amino acid 21. Sry-γ has altered gene regulation of the Sry1 promoter due to changes at amino acid 76.
Conclusions: The duplication of Sry on the Rattus norvegicus Y-chromosome has led to proteins with altered functional
ability that may have been selected for functions in addition to testis determination. Additionally, several other genes
not normally found on the Y-chromosome have duplicated new copies into the region around the Sry genes.
These suggest a role of active transposable elements in the evolution of the mammalian Y-chromosome in
species such as Rattus norvegicus.
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The testis determining gene Sry on the mammalian
Y-chromosome triggers the testis development pathway in
placental mammals [1]. It encodes a protein that is com-
posed of a highly conserved three helix HMG domain with
additional hinge and bridge domains. Variations are found
in the N- and C-terminal domains among species. In most
mammals, Sry is found as a single locus; however, rodent
species [2-5], have been reported to show copy number* Correspondence: milsted@uakron.edu
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reproduction in any medium, provided the orvariation (CNV). CNV of Sry has been detected in humans
exposed to radiation or those with sex chromosome related
anomalies [6,7]. In Rattus norvegicus, multiple loci of Sry
are expressed and code for proteins with altered amino
acid sequences [8]. These loci have been suggested to func-
tion in the development of increased blood pressure in the
Spontaneously Hypertensive Rat (SHR) compared to the
normotensive Wistar Kyoto (WKY) [9]. One locus, Sry3,
has been detected in SHR but not in WKY, and codes for a
protein that has amino acid differences altering promoter
regulation of renin-angiotensin system genes [10]. The en-
tire rat Y-chromosome for Rattus norvegicus has yet to be
assembled, thus limiting full understanding of gene dupli-
cation and divergence of Sry copies. Using newly deposited
BAC clone sequences from the SHR rat strain (SHR/Akr),Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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identifying several new Sry loci. The multiple copies of
Sry code for proteins with amino acid variations result-
ing in functional changes to promoter activity and nu-
clear localization.
Results
Identification of Sry Copies in the Rattus norvegicus
SHR strain
Several BAC sequences for the SHR/Akr Y chromosome
have been deposited in Genbank. We have combined
our past analyses of Sry in this strain with these new se-
quences, to identify contigs that include various Sry loci
(Table 1). The current number of identified Sry loci in
Rattus norvegicus is eleven. The novel eleventh locus we
have designated as nonHMG Sry due to a frame shift
mutation yielding a protein with an incomplete HMG
box.
The assembly of the Sry region has resulted in two
aligned contigs of 432 kb and 377 kb, respectively. Using
these contigs, the location and identity of multiple Sry
loci were mapped (Figure 1). The first contig (Contig 1)
contains Sry4, nonHMG Sry and Sry4A while the second
(Contig 2) contains Sry1, Sry3C, Sry3B, Sry3BII, Sry2,
and Sry3A. In addition to the Sry loci found in these two
contigs, two additional previously identified Sry loci
(Sry3 and Sry3BI) did not map to either contig. Repeat-
masker identified a high level of LINE L1 elements in
both Contig 1 (31.38%) and Contig 2 (32.77%) relative to
DNA sequence flanking the single copy of human SRY
(hSRY, 18.88%) or mouse Sry (mSry, 17.70%,) (Additional
file 1: Figures S1-S4). Alignment of sequences for the
multiple rat Sry loci reveals regions conserved among
the various copies (Additional file 1: Figure S5). Many of
the sites where homology is lost are flanked by LINE L1
elements (blue, Figure 1). Phylogenetic analysis using theTable 1 BAC sequences used to assemble the Sry region of th
BAC Sry gene(s) BAC status Li
AC242859 Sry3A Complete R
AC239701 Sry4 Complete R
AC239865 nonHMG, Sry4A Complete R
AC239814.3 Sry4 working draft R
AC239817 Sry3B Complete R
AC239866.3 nonHMG working draft R
AC243747.5 Sry3C, Sry3B working draft R
AC243673 Sry3C Sry4A working draft R
AC243442 Sry4A, Sry3C, Sry1 working draft R
AC242641 Sry3A, Sry3BI working draft R
AC241808.7 Sry3B, Sry3BII, Sry2 Complete R
AC240535 Sry3BII, Sry2 Complete Rsequence conserved in Sry copies in these contigs shows
clustering of the Sry3 loci (3BII, 3A, 3B, 3C) and a separate
clustering of Sry4 and Sry4A (Additional file 1: Figure S6).
Newly identified Sry copies in other Rattus
norvegicus strains
Four novel Sry sequences (nonHMG Sry, Sry4, Sry4A
and Sry3BII) were identified in the SHR/Akr in this paper.
Of these, the nonHMG Sry sequence was confirmed from
genomic DNA, with 100% sequence homology in SHR/
Akr [GenBank: KC215139], WKY/Akr [KC215140], and
SD/hsd [KC215141] strains. Sry4, Sry4A and Sry3BII were
confirmed in both SHR/Akr and WKY/Akr strains using
PCR reactions and selective restriction digests designed to
differentiate loci based on PCR products (Additional file 1:
Figure S7).
Identification of other loci in the Sry region of the SHR
Y-chromosome
The zinc finger on the Y (Zfy) locus is found between
Sry4 and the nonHMG Sry. This locus is found on many
other mammalian Y-chromosomes near Sry. In addition
to Zfy, we have identified a possible Med14 locus between
Sry4 and the nonHMG Sry. Normally Med14 is found
on the mammalian X-chromosome, where it contains
31 exons separated by large introns. The form identified
on the Y-chromosome of SHR is spliced, containing 30 of
the normal 31 exons of the long form Med14 of the X-
chromosome (Additional file 1: Figure S8). Located 1kB
from the Med14Y sequence (red, Figure 1) is an LTR/
ERVK element (purple, Figure 1). The presence of both an
LTR element and spliced exons suggests that this copy has
been retrotransposed onto the Y-chromosome. The pro-
tein coded by Med14Y would be highly homologous to
the X-chromosome Med14 (Additional file 1: Figure S9)
if it could be transcribed and translated. In addition toe SHR Y-chromosome
brary Fragments Bases Date deposited
NAEX 1 99871 Dec 2010
NAEX 1 138396 Dec 2010
NAEX 1 268785 Dec 2010
NAEX 1 331097 Sept 2011
NAEX 1 97422 Dec 2010
NAEX 23 92289 Feb 2010
NECO 7 165825 Apr 2011
NECO 13 153940 Apr 2011
NECO 11 100422 Dec 2010
NECO 6 144578 Sep 2010
NECO 1 156555 Jun 2011
NECO 1 153894 Dec 2010
Figure 1 Contigs containing the multiple Sry genes of the SHR Y-chromosome. Sry genes are shown in yellow, other genes (Med14, Zfy,
Ccdc110, and HMGB1) in red, LINE-1 elements in cyan, LTR elements in purple, and SINE elements in green. Numbering is given for major positions
(such as the ATG start codons and loss of homology between copies) in red relative to the beginning of each contig.
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after Sry4A) and a HMGB1-like locus (Contig 2, between
Sry2 and Sry3A, Figure 1).
Sry protein sequence comparison
Translating each of the Sry loci into protein sequences
(Table 2) allows for comparison of amino acid variations.
The eleven Sry loci can be translated into nine (Sryα-Sryθ
and nonHMG Sry) different protein sequences. Several Sry
loci encode the same protein sequence; therefore, we cre-
ated a new naming system for the Sry proteins using Greek
letters to help to differentiate protein naming from the Sry
loci naming. The Sry3/Sry3C (Sryγ used to symbolize
the protein) and Sry3B/Sry3BII (Sryε) loci translate to the
same protein sequences (Figure 2). Sequence alignments
of all Sry proteins reveal variation at amino acids 4, 21,Table 2 Sry proteins encoded on the SHR Y-chromosome with
Sry gene Sequenced BACs (s) Protein product Co
nonHMG Sry AC239865.4 Predicted
Sry1 AC243442 α
Sry2 AC240535.5 β
Sry3 Not yet identified in BACs γ
Sry3A AC242859.2 δ
Sry3B AC241808.7, AC239817.2 ε
Sry3BI AC242641 ζ
Sry3BII AC240535.5, AC241808.7 ε
Sry3C AC243442 γ
Sry4 AC239701.6 η
Sry4A AC239865.4 θ38, 76, 83, 98, 150, 152, 156 and in the Q-repeat length of
the C-terminus. The nonHMG Sry codes for a highly di-
vergent sequence containing the first helix and nuclear
localization site of normal Sry (red, Figure 3), but due to
a frame shift mutation the sequence diverges after this re-
gion. This protein sequence following the frame shift mu-
tation contains a high level of Lys and Gln amino acids
(Figure 3), indicating a high potential for interactions with
other proteins.
Using the DNA sequence, starting at the ATG start
codon and extending through the stop codon of each Sry
copy, phylogenetic analysis was performed comparing rat
Sry copies to Muennink’s Spiny rat (Tokudaia muenninki)
copies, mSry, and hSRY (Figure 4). All the proteins coded
by the Sry3 loci (Sryγ-Sryζ) cluster together (as also con-
firmed through conserved amino acids), as do those fromGenBank accession codes












Figure 2 Sequence alignments of the proteins coded for by the multiple Sry loci. The Greek symbol for each Sry protein is included to the
left of each gene name. Amino acid variations are highlighted in red with the rat protein numbering system used to identify the location of
these variations.
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using the maximally conserved sequences (Additional
file 1: Figure S6). The phylogenetic analysis suggests
the possibility that a Sry locus, present before the Sry2
split from Sry1, Sry4 and Sry4A, may have been the ori-
ginal locus in rodents prior to copy number increase.Figure 3 Sequence of the nonHMG Sry with ProtParam statistics. Sequ
by a frame shift mutation leading to a different protein sequence. The pred
This protein sequence contains a high percentage of Gln (10.7%) and Lys (Inspection of individual amino acids found in the rat Sry
copies when compared to human and mouse protein se-
quences supports this claim (Figure 2 and Additional file 1:
Figure S10). As expected, the nonHMG Sry sequence is
highly divergent from all other Sry, a likely result of drift
following the frame shift mutation.ence shows the conserved first helix of the HMG box in red, followed
ictions for molecular weight, pI, and extinction coefficient are given.
9.3%) as can be seen in the amino acid percentages.
Figure 4 Phylogenetic analysis of the coding region of the multiple rat Sry. Phylogenetics of the coding region of the rat Sry genes
compared to the mouse Sry, three copies of Tokudaia muenninki, human and the nonHMG. Numbers next to each node represent the percent of
the 500 bootstrap phylogenies that were identified similar to the one shown in the figure.
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To analyze functional variation of amino acid differences
in the multiple Sry proteins, this study used both model-
ing and site directed mutagenesis. Three amino acid
sites differ in the HMG box (amino acids 4, 21 and 38;
Figure 2 and Additional file 1: Figure S10) and an add-
itional amino acid site in the highly conserved hinge do-
main (amino acid 76; Figure 2 and Additional file 1:
Figure S10). Amino acids 4, 21, and 76 additionally fall into
nuclear localization signal sites [11,12]. Using a modeled
structure of the protein coded by the Sry1 locus (Sryα)
interacting with DNA (cyan, Figure 5A), it can be seen that
substitutions in amino acids 4, 21 and 76 (red, Figure 5A)
may have a slight propensity to alter DNA binding stability
(Figure 5B) and energy (Figure 5C and Additional file 1:
Figure S11).
Sryα binds to DNA elements that are known to be
bound by hSRY in a sequence specific manner (Figure 6A).
Use of a control EBNA DNA (lane 1) is shifted by EBNA
protein extract (lane 2), with the shift outcompeted with
unlabeled DNA (lane 3). Adding Sryα lysate to this EBNA
DNA does not shift the band (lane 4), confirming specifi-
city of DNA sequence for binding. Taking a Sry DNA bind-
ing element and adding the EBNA protein did not result in
a shift (lane 5) while addition of Sryα lysate did (lane 6).
The Sryα binding is competed off with unlabeled Sry DNA
(lane 7). The shifting of the DNA was concentration
dependent on Sryα lysate (Figure 6B-C). This confirms for
the first time that Sry protein from Rattus norvegicus can
bind to similar DNA sequences as human and mouse.
Sryα and Sryγ primarily localize to the nucleus of the
cell, while Sryβ is also found in the cytoplasm (Figure 7).
Mutating amino acid 21 in Sryα from an Arg to a His
(Sryα R21H) resulted in more Sry localization in the cyto-
plasm, while mutating amino acid 21 in Sryβ from His to
Arg (Sryβ H21R) abolished the cytoplasmic localization.This confirms that changes to amino acid 21 can alter
cellular localization, while changes at amino acid 38 and
76 likely have minimal change to cellular localization
(comparing Sryα and Sryγ).
The presence of Thr at amino acid 76 defines the Sry3
subgroup (Sryγ-Sryζ, Figure 2). Sry in all other mamma-
lian species (340 species analyzed to date), every mem-
ber of the Sox subfamily to which Sry belongs, and rat
Sryα/β/η/θ proteins all contain a Pro at amino acid 76.
Comparing Sryα to Sryγ, only two amino acids vary (38
and 76). The Sry1 promoter is differentially repressed by
Sryα and Sryγ compared to the control or each other
(Figure 8A). When amino acid 76 is mutated in Sryα from
a Pro to a Thr, this decreases the Sry1 promoter regulation,
yielding less repression relative to Sryα (Figure 8B). Chan-
ging amino acid 76 in Sryγ from a Thr to a Pro increased
Sry1 promoter repression relative to Sryγ (Figure 8C).
Changing amino acid 38 from His to Gln in Sryα had no
effect on the promoter regulation (Figure 8B). In con-
trast, when amino acid 38 of Sryγ was changed from Gln
to His, promoter repression was decreased relative to Sryγ
(Figure 8C).
Comparing the proteins from the Sry4/4A loci (Sryη/θ
proteins) with those of the previously identified Sry pro-
teins, amino acids 4, 21, and 38 are conserved with Sry
γ-ζ (the Sry3 loci), while amino acid 76 is shared with
Sryα, Sryβ and all other known mammalian Sry proteins
(Figure 2 and Additional file 1: Figure S10). Two unique
amino acid variations from the rest of the rat Sry proteins
are found in the bridge domain of Sryη/θ. Mutations of
Sryα at amino acid 98 (from a Leu to Val designated as
Sryα L98V, similar to Sryθ) showed a trend towards de-
creased repression of the Sry1 promoter relative to Sryα
(Figure 9). A double mutant (similar to Sryη) at amino acid
98 and also 83 (Pro to Ser; Sryα P83S/L98V) showed regu-
lation similar to the single mutant construct (Sryα L98V).
Figure 6 Binding of Sryα to a known Sry-DNA binding element. A) Control experiments for Sryα specific binding. The protein and DNA
identities for each lane can be seen in the box next to the gel. B) Concentration curve for extract amounts of Sry1 transformed E. coli cell lysates
expressing Sryα protein. C) Densitometry measurements of the Sryα-dsDNA and dsDNA bands mapped relative to lysate volume.
Figure 5 HMG box variations in the rat Sry proteins. A) Amino acid variations (red) found in the HMG box of rat Sry proteins shown on a model
of Sry1 (gray) when bound to DNA (cyan) based on the known human structure. B) Averaged movement during molecular dynamic simulations for
models of Sryα interacting with DNA with each mutation from A. Shown as the averaged carbon alpha RMSD for the structure over a 1 nanosecond
simulation. C) Predicted binding energy to DNA of the energy minimized structures of Sryα or containing one of the four mutations in Sryα.
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Figure 7 Immunocytochemical and Western blot analysis of native and mutated Sry protein cellular distribution. Cells were transfected
with Sryα (top), Sryβ, Sryγ, Sryα R21H, or Sryβ H21R (bottom) and analyzed with microscopy and western blot for cellular distribution. The first
(left most) column of images shows the transfected CHO cells visualized with light microscopy, the second with Cy3 (red) detection of the
respective Sry (with Cy3 conjugated to the secondary antibody recognizing the Sry specific antibody), third the DAPI staining (blue, recognizing
the nucleus) with Cy3 overlay, and the fourth (right most column) the overlay of all columns allowing for identification of the nucleus and cell
outline together with Sry expression (red). To the right of the images of the cells are western blots of the nuclear and cytoplasmic fractions from
CHO cell lysates. Sryα and Sryγ proteins localize exclusively to the nucleus while Sry β is distributed in both the nucleus and cytoplasm. Chimeric
Sry β(H21R) encodes an R at residue 21, as seen in Sryα/γ, rather than H, while Sry α(R21H) proteins contain a H residue at position 21 as see in
native Sryβ. The resulting staining patterns demonstrate that an R encoded at position 21 stimulates nuclear localize while a H at this position as
see in native Sry β and chimeric Sryα (R21H) results in cytoplasmic accumulation. Western blots of nuclear and cytoplasmic extractions support
the results from the immunocytochemical analysis.
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Sry1 promoter construct; however, this variant is not found
by itself in any of the rat Sry copies.
Sry proteins with different lengths of the Q-rich C-
terminal region (Sryα, Sryβ and Sryγ, Figure 2) activate
the AR600 promoter construct at various levels com-
pared to the control (Figure 10A). Sryβ has a deletion of 13
amino acids when compared to Sryα and Sryγ (Figure 2).
Removing these 13 amino acids from Sryα, creating a con-
struct known as Sryα(del), decreased promoter activity
compared to the wild type Sryα (Figure 10B) yielding simi-
lar values as Sryβ. Completely removing the 25 amino
acids of the Q-rich region of Sryα, known as Sryα(−QR),
resulted in minimal regulation of the promoter as did
a construct containing only the HMG box of Sryα
(Figure 10B). Sryβ with the 13 Q amino acids of Sryα or
Sryγ added, known as Sryβ (+QR), increased promoter ac-
tivity compared to Sryβ, yielding a value similar to Sryα
and Sryγ (Figure 10C). The complete removal of the
Q-rich region of Sryβ, Sryβ (−QR), caused a complete
loss of promoter regulation. Similar results to mutations
of Sryα (Figure 10B) were seen when the deletions were
made to Sryγ (Figure 9D). Modeling the Q-rich region andthe remaining C-terminal end of rat Sry (Figure 11A)
shows the locations of variations outside of the HMG box
mapped onto the structure of Sryα interacting with DNA
(Figure 11B, Additional file 2).
Discussion
Multiple Sry loci in Rattus norvegicus are known to be
expressed [8]. Sequencing of the SHR/Akr rat Y chromo-
some is under progress by the Y chromosome project
(http://www.genome.gov/25521746). Identifying and la-
beling all the Sry loci and functional variations are of im-
portance for both annotating Y-chromosome sequence
data and for understanding how each of these Sry loci
functions. The SHR/Akr strain has been shown to have
loci on the Y-chromosome that are associated with blood
pressure increases [13,14] and other sympathetic nervous
system phenotypes reviewed in [15]. Animals with the Y-
chromosome of SHR and WKY autosomes have higher
blood pressure than WKY males [14]. Studies have re-
vealed the inability to amplify the Sry3 locus, present in
SHR, from WKY genomic DNA, suggesting a potential in-
crease in CNV of SHR over WKY [9]. Delivery of the cod-
ing sequence of either Sry1 [16] or Sry3 [17] but not Sry2
Figure 8 Regulation of the Sry1 promoter by Sryα and Sryγ. A) Sryα (blue) and Sryγ (green) transfected CHO cells significantly repress the
Sry1 promoter construct when compared to empty vector control (black) or each other (bar above Sryα and Sryγ). B) Sryα and mutations of Sryα
at amino acids 76 (Sryα P76T) and 38 (Sryα H38Q) transfected into CHO cells all repress the Sry1 promoter construct when compared to empty
vector control (black), with the P76T and not H38Q significantly differing from Sryα. C) Sryγ and mutations of Sryγ at amino acids 76 (Sryγ T76P)
and 38 (Sryγ Q38H) transfected into CHO cells all repress the Sry1 promoter construct when compared to empty vector control (black), with the
T76P and Q38H significantly differing from Sryγ. For all figures error bars represent the standard error of the mean and statistical significance is
shown as ∗ = p≤ 0.05, ∗∗ = p≤ 0.01, ∗∗∗ = p≤ 0.001.
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blood pressure increase through the renin-angiotensin sys-
tem and the sympathetic nervous system. With Sry3
present in SHR but not detected in WKY [10], this
additional copy of an Sry gene (Sry3) may be largelyFigure 9 Activity of the Sry1 promoter with amino acid
changes found in Sryα and Sryη/θ. Sryα and Sryα mutated at sites
corresponding to Sryη/θ amino acid differences (P83S, L98V, and
P83S/L98V double mutant) transfected into CHO cells and regulating
the Sry1 promoter construct when compared to empty vector
control (black). Error bars represent the standard error of the mean
and * = p≤ 0.05 comparing each value to the control while # = p≤ 0.05
comparing Sryα and Sryα P83S.responsible for the blood pressure elevation seen in
Y-chromosome crosses of the consomic strains [13,14].
Y-chromosome sequence analysis has revealed at least
eleven Sry loci on the Y-chromosome of Rattus norvegi-
cus SHR/Akr that code for nine different proteins. It is
possible that additional loci exist and have yet to be se-
quenced; sequencing of the SHR/Akr Y-chromosome is
still underway. We do not know which Sry locus codes
for testis determination in Rattus norvegicus or if mul-
tiple loci contribute to this function. It may be possible
that any of the ten Sry loci (excluding the nonHMG Sry)
could determine sex if expressed with proper developmen-
tal timing. Four new loci were detected in this current
study. These were previously unidentified due to an inser-
tion of DNA after the 3’ untranslated region in these newly
identified loci, preventing PCR amplification with the pri-
mer sets previously used. New primer sets and restriction
digests allowed us to identify these new loci in both SHR
and WKY rats.
Compiled contigs for the Y-chromosome region con-
taining the Sry loci in Rattus norvegicus allow for identi-
fication of possible mechanisms of gene duplications. Of
the four loci identified in our contigs that are not Sry
(Zfy, Med14, Ccdc110, and HMGB1), several are flanked
by repetitive elements that may have contributed to locus
positioning on the Y-chromosome. An LTR/ERVK element
was identified 5’ of the start codon of the Med14Y. This
Figure 10 Function of the Q rich region of the C-terminal end of Sry. A) Regulation of the AR600 promoter construct by Sryα (blue), Sryβ
(red) and Sryγ (green). Multiple mutations made to Sryα (B), Sryβ (C) or Sryγ (D) that altered AR600 promoter regulation. For Sryα three deletion
constructs were created (B): Sryα(del) removing 13 amino acids in the Q-rich region making it more similar to Sryβ, Sryα(−QR) removing the
whole 25 Q-rich region, and Sryα(HMGbox) containing only the HMG box of Sryα . For Sryβ two alternative constructs were created (C): Sryβ(+QR)
adding the 13 amino acids of Sryα in the Q-rich region missing from Sryβ, Sryβ(−QR) removing the entire 25 amino acids of the Q-rich region.
Two alternative constructs were created for Sryγ (D): Sryγ(del) removing 13 amino acids in the Q-rich region making it more similar to Sryβ,
Sryγ(−QR) removing the whole 25 Q-rich region. Error bars represent the standard error of the mean and significance is shown as ∗ = p≤ 0.05,
∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001 for each compared to the control (black).
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Med14, however it is missing the normal introns, sug-
gesting retrotransposition of a mature mRNA onto the
Y-chromosome of rat. An LTR element has also been iden-
tified 3’ of the Zfy and 5’ of the Ccdc110 loci. Currently we
do not know the function or conservation (presence and
spatial organization) of these loci on the Y-chromosome
in other rat species. Future work will be required to de-
termine the dynamic gene evolution occurring in rat
Y-chromosome evolution.
The largest conserved fragment of DNA sequence within
the contigs is between Sry4 and Sry4A, with a large region
of 3’ conservation (around 43 kB). Analysis of the conser-
vation revealed a LINE L1 element (cyan, Figure 1) con-
served at the point where homology is lost; this LINE L1
appears to have the proper sequences to code for proteins
of both ORFs required for LINE L1 transposition. Flanking
several other loci (Sry3C and Sry3A) are insertions of LINE
L1 elements relative to the other loci, suggesting more re-
cent LINE L1 insertions after copy number increased. SOX
genes have been shown to regulate the promoters of LINE-
L1 elements [18] suggesting a potential interplay between
Sry and LINE-L1. These elements, as well as sequence vari-
ations, may alter the expression of the various loci, as has
already been shown [8]. The Sry2 gene is preferentially
expressed in adult adrenal glands relative to testis, while
the combination of Sry1, Sry3 and Sry3C is expressed at ahigher level in the testis relative to adrenal. The Sry3C
locus shares a high level of conservation with the 3’ end of
Sry2 and a lower level with Sry1. These observations sug-
gest that Sry3C may have resulted from the original dupli-
cation event and then further duplicated and differentiated
to give the remaining Sry3 subgroup members. Identify-
ing the mechanism of duplication and order of events is
complicated by a continual change to all loci after the du-
plication events occurred. This may be simplified by un-
derstanding the organization of the Y-chromosome and
Sry sequences in other Rattus norvegicus strains and other
rodent species. For example, our initial sequence analysis
comparing the Rattus norvegicus and Tokudaia muenninki
Sry copies did not reveal any connections between the du-
plicated copies at either the DNA or amino acid level, in-
dicating that Sry duplication has occurred more than
once. Understanding the duplication events in the rat may
help to explain duplications of SRY seen in humans ex-
posed to radiation or with Turner syndrome [6,7].
Amino acid differences among the proteins coded by the
multiple Sry loci result in functional variation. From the
eleven loci, we predict nine protein sequences (Sryα-Sryθ
and the nonHMGSry). Sryβ has several amino acid varia-
tions in nuclear localization sites (amino acids 4 and 21)
and also the C-terminal end (Figure 2 and Figure 11). Sry
protein localizes to the nucleus using two different local-
ization signals (NLS) [19]. The first NLS is found as a
Figure 11 Structural model of full-length rat Sryα protein. A) The modeled C-terminal end containing the Q-rich region of Sryα showing the
electrostatic surface as determined with Poisson-Boltzmann Solver (blue is positive charge and red is negative charge). The model was rotated
90° on the Y-axis for four views yielding a 360° structural analysis. The model had a quality score (z-score) of −1.564 as determined with the
YASARA2 force field (anything greater than −2 is considered a fair model), and contains no wrong isomers or cis-peptide bonds. B) Ribbon view
of the structure of the C-terminal segment (as seen in the left most image in A) added to the HMG box of Sryα bound to DNA (cyan). Amino acid
variations between the multiple rat Sry loci falling outside the HMG box are shown in red with the rat numbering system used (Figure 2).
Prokop et al. BMC Genomics 2013, 14:792 Page 10 of 15
http://www.biomedcentral.com/1471-2164/14/792bipartite signal known to interact with calmodulin [20-22].
Amino acid 4 falls into the NLS in the first of the bipartite
sequences and amino acid 21 in the second. Mutations of
amino acid 21 in Sryα decreased nuclear localization, and
models for the interaction between Sry and calmodulin
suggest a decreased interaction when amino acid 21 is a
His (Additional file 1: Figure S12).
All the Sry3 loci (Sryγ-ζ proteins) contain a threonine
at amino acid 76, rather than the normal proline. A pro-
line is found at this amino acid in all human SOX genes
(and all other vertebrate and invertebrate Sox genes ana-
lyzed to date by our lab) and all mammalian Sry sequences[23]. Variation at amino acid 76 in hSRY is associated with
sex reversal [24]. This suggests a high degree of conserva-
tion, likely required for proper DNA bend angle, protein
recruitment, and gene regulation [20]. Amino acid 76 falls
in the second NLS which is thought to work through
importin-β1 [25]. Both Sryα and Sryγ localize to the nu-
cleus (Figure 7), and changes from a proline to a threonine
at amino acid 76 do not seem to alter nuclear localization.
Promoter activity assays show that the proline to threonine
change in Sryα leads to changes in activity. Modeling ap-
proaches and proline to threonine mutations also showed
altered regulation of renin-angiotensin system promoters
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tions on our Sryα and Sryγ constructs at amino acid 38 al-
tered promoter regulation for Sryγ only. This suggests that
changes to amino acid 38 may compensate for the loss of
activity seen when also changing amino acid 76. It should
be noted as two amino acids vary between these con-
structs, Sryα P76T and Sryγ Q38H yield the same mutant
proteins as do Sryα H38Q and Sryγ T76P. The Sry1 pro-
moter regulation for these constructs showed no difference
when compared to each other, and serve as an internal
control to validate that the changes in regulation could
only be due to changes at these two amino acids.
Sryη and Sryθ proteins (produced from the Sry4 and
Sry4A loci) show amino acid variation in the bridge do-
main. The Sry4 genes have not been cloned and analyzed
for expression, so Sryα was chosen for mutagenesis. Amino
acid 76 (shown to result in significant functional alterations
when a Thr and not a Pro) is conserved among Sryη/Sryθ
and Sryα, therefore making Sryα a better choice than the
Sryγ or Sryβ protein constructs to use for mutagenesis.
Analysis of amino acid variations among the multiple loci,
suggests that Sry4 and Sry4A are very old loci as they alone
(relative to the other Sry copies) share amino acid 83 with
mouse (Additional file 1: Figure S10). With the variations
of Sryη and Sryθ amino acids falling in the bridge domain,
they may alter the interaction with proteins known
to interact through the bridge domain of Sry, such as the
KRAB containing proteins [26], resulting in altered epigen-
etic gene silencing of Sryη/Sryθ regulated genes [27].
The C-terminal end contains the largest area of vari-
ation among the Sry proteins of Rattus norvegicus. There
are no known structures for regions outside the HMG
box of Sry. With the lack of high sequence conservation
of the C-terminal end with other species, it is difficult to
determine the importance or functionality of this do-
main. It has been suggested that the C-terminal end can
interact with and stabilize DNA binding [28]; however, it
is also likely that this domain serves to recruit other pro-
teins to the DNA. Based on the number of charged amino
acids on the surface of the C-terminus (Figure 11A), which
also contains a hydrophobic packed structure (Additional
file 2), interactions with other proteins (yet to be identi-
fied) are possible. The stretch of 13 amino acids deleted in
Sryβ alters regulational ability of Sry as does the deletion
of the entire Q-rich C-terminal domain. These results sup-
port the importance of this region in rat Sry function, even
though the region does not share conservation with most
other mammalian Sry sequences. It is possible that func-
tions of the Sry N-terminus in all other mammalian spe-
cies [29,30] have been translocated to the C-terminus
of rodent Sry. Since the structure of Sry places both
the N and C-terminus flanking the HMG box in the same
spatial area, one could easily be functionally substituted for
the other.Current work is underway to compile and annotate the
Y-chromosome of the SHR/Akr strain. In labeling the mul-
tiple loci of Sry, care needs to be taken in naming as we
show in this study and others that there are functional vari-
ations in the proteins, with differential expression patterns
of each. Understanding the mechanisms of the gene dupli-
cations seen in this animal model may lend insights into
the duplication and transpositions of Sry in many human
diseases such as sex reversal. Ultimately, studies such as
this allow us to begin to understand evolution of the lesser
studied Y-chromosome in an animal model to understand
complex diseases such as hypertension, while also address-
ing the evolution of the Y-chromosome in mammals.
Conclusions
Currently we know of eleven Sry copies on the Rattus
norvegicus Y-chromosome with additional copies of Zfy,
Med14, Ccdc110, and HMGB1 in this region. Transpos-
able elements seem to play an active role in the duplica-
tion and translocation of these genes. The duplication
events have led to Sry proteins that have amino acid var-
iations that lead to functional alterations in nuclear locali-
zation and transcriptional activity. These results show
some of the dynamic processes involved in the evolution of
the Y-chromosome and suggest importance in numerous
disease models such as hypertension.
Methods
Identification of Sry proteins
The sequence of the Sry1 locus (EU984075) was blasted
against the NCBI Rattus norvegicus sequences. Protein
sequences were translated from BAC clones or sequenced
constructs using Expasy translate, and aligned by hand.
Several new loci (Sry3BII, Sry4 and Sry4A) were confirmed
by PCR using primers specific to these loci, JP1R (5’-ccaaa
tacagcaaggctgag) and JF8L (5’tgtaaggggtaaaagctagtatcc) pri-
mer set, with Phusion Hot Start II (Thermo Scientific) on
both SHR and WKY genomic DNA (cycling conditions:
98°C-3 min, 98°C -30 sec, 56.8°C -30 sec, 72°C -45 sec, re-
peats steps 2–4 35 times, 72°C -5 min, 4°C-hold). Reactions
were run on 1% agarose gels and the bands were iso-
lated using IBI gel extraction kit (MidSci). Fragments
were used in either restriction digest with Afl II or a nested
PCR using L-BamH1/KozakSry (ctaggatccgaaccatggagggcc
atgtcaag) and R-Not1-StopcodonSry (ctagcggccgctcgtggaac
tggtgctgct) with GoTaq polymerase (Promega; cycling
conditions: 94°C-4 min, 94°C-1 min,60°C-35 sec,72°C-
1 min, repeat steps 2–4 30 times, 72°C-7 min, 4°C-hold).
Contig design, repeat detection, sequence alignments,
and phylogenetics
Contigs were built using the sequenced BACs of Table 1.
In short, all sequences were compiled with Sequencher
4.5 (Gene Codes) using max inputs for alignments. For
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pairs) were removed to exclude low sequence depth areas.
The previously identified Sry sequences were then aligned
to the contig with 100% identity. Repetitive sequences were
identified using RepeatMasker [31] with abblast, default
speed, rat as the DNA source, no contamination checks,
and simple repeats not masked. To compare the rat trans-
posable elements on the Y-chromosome, mouse and hu-
man Y-chromosome sequences flanking the respective Sry
were used (using the DNA source of the respective species
for the RepeatMasker analysis). The Sry loci were aligned
to each of the other loci to identify the conserved fragment
size using Clustal Omega [32] with default settings. A min-
imal conserved fragment size around Sry was identified
for all the Sry loci present in the contigs. Phylogenetics
were performed using MEGA-5 [33] on this minimal frag-
ment or the ORF for each of the rat Sry loci with hSRY
[GenBank: CCDS14772] or mSry [GenBank: CCDS30545]
using maximum likelihood with the JTT model and 500
bootstrap replications.
Mutagenesis and promoter cloning
Mutations of the rat Sry pEF-1 expression vectors were
created with site directed mutagenesis using Phusion
Hot start Taq (Thermo Scientific). The respective primer
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tatttctctctgtgcatggc) were phosphorylated with T4 poly-
nucleotide kinase (Fermentas) and used in PCR. T4 DNA
ligase (Fermentas) was used to ligate linear vectors and
these were transformed into TAM-1 competent E. coli
(Active Motif ). Sryα/γ(del) constructs were created by
amplifying Sry from each construct with L-BamH1/
KozakSry and R-Not1-StopcodonSry and digested with
Cvi QI which cuts at base pair 294. The C-terminal end of
Sryβ (containing a 13 amino acid deletion from Sryα/γ)
was ligated together with the N-terminus of Sryα/γ. For
Sryβ(+QR) the N-terminus of Sryβ was ligated with
the 13 amino acid larger fragment of Sryα. An HMG
only construct (Sryα(HMGbox)) was created by amplify-
ing Sryα with L-BamH1/KozakSry and R-SryXbaBoxOnly
(ctctagactgtggcactttaaccc), followed by T4 ligation to re-
circularize the vector. Constructs without the C-terminal
Q-rich region were created by PCR with L-BamH1/KozakSry and R-SryXba-QR (ctctagatgggtatccagtgg) gener-
ating a 142 amino acid protein from each Sry (Sryα(−QR),
Sryβ(−QR), Sryγ(−QR)).
The two promoter constructs used in luciferase assays
were the Sry1 and AR600 constructs. A pGL3 rat Sry1 pro-
moter construct (−3317/+10, +1 designating the proposed
transcriptional start site) was created by amplification from
cloned Sry1 DNA [GenBank: KC215142] with L-Sry1NheI
(5’-CTATGCTAGCTCCATACCAAGAAGGCAGTTG-3’)
and R-Sry1HindIII (5’-CGCAAGCTTAAACCCCTGTG
GATTGTAAATG-3’). The rat Sry1 promoter contains
multiple potential Sry binding sites as determined by
MatInspector (Genomatix). This fragment was cloned into
pGL3 with Nhe I and Hind III restriction digest. The
pGL3 AR600 construct (containing the 5’ UTR of AR,
with several potential Sry binding sites) was created by
PCR with R-ARNco (gtaccatggtttagcttgtctctagcttccacc) and
LARSma600 (cacccgggtaactccctttggctga) and cloned in
with Nco I and Sma I restriction digest and ligation. All
clones and mutations were sequence confirmed using
BigDye Terminator chemistry on ABI 3130xl genetic
analyzer (Applied Biosystems).
Electrophoretic mobility shift assays (EMSA)
Sry1 DNA was inserted into the pIVEX 2.4 with GoTaq
(Promega) PCR using 5’- gcgcccgggctagtggaactggtgct and
5’- gcggcccatggagggccatgtcaag with NcoI and Sma I digests,
followed by T4 ligation. Vector was transformed into BL21
(DE3) competent E. coli (NEB). A single isolated colony of
cells was inoculated into 5 mL terrific broth containing
50 ug/mL Ampicillin and grown to OD600 of 0.8 at 37°C.
Cells were induced with 0.75 mM IPTG and incubated at
37°C for three hours. Cells were collected at 5000×g for
10 min and frozen at −80°C until lysis. Cells were lysed
with 1 mL of 1× CelLytic B (Sigma-Aldrich), 2 mg/mL
Lysozyme, 0.25 mM Leupeptin, 1 mM PMSF, 50 Units
DNase, 25 mM NaF, 25 mM MgCl in phosphate buffered
imidazole. Cells were passed through a 25 gauge needle
multiple times to complete lysis and the lysate was centri-
fuged at 10,000 × g for 20 min.
Freshly annealed primers (5’-CATACTGCGGGGGTG
ATTGTTCAGGATCATACTGCG-3’ and antisense), con-
taining a 5’ conjugated biotin (IDT) on the sense strand
(primers were previously used by another lab to confirm
hSRY-DNA binding [34]) were prepared in primer an-
nealing buffer (10 mM Tris, 1 mM EDTA, 100 mM NaCl,
pH 8.0) at a final concentration of 10 μM. Annealed
primers were diluted to 250 fmol/μL. Non-denaturing TBE
polyacrylamide gels (6%) were casted in a 0.75 mm spaced
glass cassette (Bio-Rad) with a 10 well comb and pre-
electrophoresed for 1 hr at 100 V in 0.5× TBE. Control
binding experiments were setup using the LightShift
EMSA optimization and control kit (Thermo). All reac-
tions contained 2 μL 10× binding buffer, 1 μL 50% glycerol,
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reactions, 2 μL Biotin-EBNA control DNA, 2 μL Unlabeled
EBNA control DNA, 1 μL EBNA overexpression extract,
2 μL Biotin-Sry-DNA, 2 μL Unlabeled-Sry-DNA (2 pM),
and 2 μL Sryα cell lysate sample sizes were used. All reac-
tions were brought to 20 μL total with molecular water.
Sryα lysates ranging from 0.5 to 3 μL in 0.5 μL increments
were used to show a concentration dependence of DNA
binding. Reactions were incubated at room temperature
for 20 min. Samples were run on a TBE gel at 100 V for
45 min. A Biodyne B Nylon Membrane (Thermo) was
soaked in 0.5× TBE for 10 min. When electrophoresis was
complete, the gel was transferred to the membrane in a
semi-dry horizontal transfer system at 75 mA for 30 min.
The membrane was then dried for twenty minutes at room
temperature, cross linked using UV light and detection
was performed as recommended in the LightShift Chemi-
luminescent EMSA kit (Thermo). ImageJ (NIH) was used
for densitometry analysis.
Nuclear localization
CHO-K1 cells (1.25 × 104 cells/cm2) used for immunocy-
tology were seeded onto LabTek™ 16 well glass chamber
slides (Nunc™) in HAM’s F12K medium (Sigma) supple-
mented with 10 mM HEPES, 30 mM sodium bicarbonate
and 10% fetal bovine serum (Atlanta Biologicals) in a hu-
midified atmosphere at 37°C with 5% CO2. After 24 hours
cells were transfected with 300 ng plasmid DNA (Sry
pEF1expression vector) using 1 μl ExGen500 in 20 μl
150 mM NaCl. After 24 hours of incubation all chambers
were washes twice with 1× PBS and fixed for 5 min in ice
cold methanol. Cell were incubated 25 min in blocking
solution (1× PBS containing 10% normal rabbit serum
and 3% nonfat dry milk) followed by incubating one hour
with the primary antibodies, goat anti-Myc epitope (Bethyl
Laboratories, Inc.) or goat anti-mouse Sry E-19 (Santa
Cruz Biotechnology, Inc.) diluted 1:450 and 1:100 respect-
ively in diluted blocking solution (2% normal rabbit serum,
0.6% nonfat milk) at 22°C. After four washes with 1× PBS,
the secondary antibody, a rabbit anti-goat IgG-Cy3™ conju-
gate (Sigma-Aldrich, Inc.) diluted 1:3500 in blocker diluted
to 4% normal rabbit serum, was added in 1.2% nonfat
milk and incubated 45 min at 37°C. After two washes in
1× PBS, VectaShield mounting medium containing DAPI
(Vector Laboratories) was applied and images were cap-
tured using a broad range excitation filter (530 – 550 nm)
on an Olympus BX60 with DP71 digital camera and DP
Controller software. Controls to ensure antibody specificity
included CHO transfected as described above with Sryα in-
cubated with normal goat serum or PBS in place of a pri-
mary antibody. In all experiments at least 12–25 stained
cells were observed per transfection.
CHO-K1 cells were grown to 1.0 × 105 cells/cm2 on
100 mm plates (Nunc™) as described previously. Each platewas transfected with 7.5 μg respective Sry pEF1 expression
vector that was complexed with 25 μl ExGen500 and
150 mM NaCl was used to bring the total reaction volume
to 1 mL. Complexes were applied to CHO in 9 mL fresh
medium and centrifuged at 280 × g 5 min. Following a
24 hour incubation, medium was removed, plates were
washed with 1× PBS and cells were trypsinized, pelleted
(280 × g, 5 min.) and cytoplasmic and nuclear proteins
were separated using the reagents and protocol supplied in
the ProteoJET™ Cytoplasmic and Nuclear Protein Extrac-
tion Kit (Fermentas). Fractions generated were quantified
by Bradford Assay (Thermo) and then subjected to SDS
PAGE and western blot analysis.
Cytoplasmic and nuclear extracts (20 μg) were separated
on 13.5% polyacrylamide gels and proteins were semidry
transferred (1 mAmp/cm2) to PVDF membranes. Blots
were blocked 1 hr at room temperature in 1× TBS con-
taining 5% nonfat dry milk and 0.1% Tween-20. Primary
antibodies used to detect Sry proteins include a goat anti-
mouse Sry E-19 (Santa Cruz Biotechnology, Inc. ) and a
goat anti-Myc epitope (Bethyl Laboratories, Inc. Labora-
tories). Both antibodies were diluted in blocking solution
at 1:300 and 1:1000 respectively and incubated for at least
1 hr at room temperature. Following two washes in 1×
PBS, the secondary antibody, donkey anti-goat HRP con-
jugate (Bethyl Laboratories, Inc. Laboratories) was di-
luted 1:6,000 in blocking solution and incubated 1 hr at
room temperature. Bands were detected using Super-
Signal West Pico Chemiluminescent Substrate (Thermo
Fisher Scientific Inc.).
Cotransfections and luciferase assays
Transfection into CHO-K1 cells was performed using
500 ng pGL3 reporter vector, 50 ng of pEF1 expression
vector, 500 pg Renilla control vector and 2uL Turbofect
(Fermentas) into 5x104 cells preplated in a 24 well plate
24 hours prior to transfections. Cells were lysed 24 hours
post transfection and luciferase assays performed with
Dual-Luciferase reported assay system (Promega) accord-
ing to the manufacturer’s instructions. Statistics were per-
formed using JMP software with statistical significance of
p < 0.05. ANOVAs were performed followed by individual
student’s t-tests. All error bars are presented as the stand-
ard error of the mean.
Modeling protein structures and molecular dynamic
simulations
Models of rat Sry tertiary structure were created using
I-TASSER [35] and aligned to DNA using the PDB struc-
ture 1j46 of human SRY [36] and energy minimized with
YASARA [37] with water at 0.998 g/mL and AMBER03
force field [38]. Models for the C-terminal end of Sryα
were created with QUARK [39]. The ten models were run
in molecular dynamic simulations for 2 nanoseconds and
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model (model 4) as determined by maximal hydrophobic
packing in md simulation, model quality (determined with
the knowledge-based potential of YASARA2), and energy
minimization was manually added onto the model of the
HMG box bound to DNA, forming the peptide bond,
followed by energy minimizations using the AMBER03
force field in water.
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